Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 16751-16800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06862089
A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV
N/ARecruiting
120 participants
Started: Oct 23, 2024 · Completed: Dec 30, 2026
3 conditions1 sponsor1 location
NCT06667960
Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer
PHASE1/PHASE2Recruiting
155 participants
Started: Oct 23, 2024 · Completed: Aug 1, 2028
1 condition1 sponsor8 locations
NCT06606327
Diazoxide Suppression Test P&F Study
PHASE1Recruiting
10 participants
Started: Oct 23, 2024 · Completed: Jan 31, 2026
3 conditions3 sponsors1 location
NCT06578234
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
PHASE4Recruiting
180 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06242795
Hypertonic Saline in NCFB
PHASE4Recruiting
20 participants
Started: Oct 23, 2024 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT06492837
Study With Mosunetuzumab and Zanubrutinib in R/R Follicular Lymphoma Patients
PHASE2Recruiting
56 participants
Started: Oct 23, 2024 · Completed: Sep 15, 2033
1 condition1 sponsor24 locations
NCT06735391
A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive Mutations
PHASE3Recruiting
516 participants
Started: Oct 23, 2024 · Completed: May 30, 2029
3 conditions1 sponsor1 location
NCT06712667
The Effect of Coffee on People with High Intensity Exercise and the Characteristics of Caffeine Metabolism
NARecruiting
24 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06736015
Myo-inositol and Selenium in Indeterminate Thyroid Nodules (TIR3a)
NARecruiting
30 participants
Started: Oct 23, 2024 · Completed: Oct 30, 2026
1 condition1 sponsor1 location
NCT07037849
The Effects of the Control Strategies of Wearable Lower Limb Rehabilitation Robots
NARecruiting
10 participants
Started: Oct 23, 2024 · Completed: Apr 22, 2027
3 conditions1 sponsor1 location
NCT06571422
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
PHASE1Recruiting
93 participants
Started: Oct 23, 2024 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT06765876
CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: a Dose Escalation Phase I Trial
EARLY_PHASE1Recruiting
18 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2028
4 conditions1 sponsor1 location
NCT06653010
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
EARLY_PHASE1Recruiting
30 participants
Started: Oct 23, 2024 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT06685744
TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
NARecruiting
300 participants
Started: Oct 23, 2024 · Completed: Jun 30, 2026
3 conditions12 sponsors6 locations
NCT06653023
Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
EARLY_PHASE1Recruiting
60 participants
Started: Oct 23, 2024 · Completed: Dec 30, 2027
2 conditions1 sponsor1 location
NCT06448637
DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)
NARecruiting
94 participants
Started: Oct 23, 2024 · Completed: May 1, 2027
1 condition1 sponsor4 locations
NCT06678048
Arsenous Acid for Refractory Triple-Negative Breast Cancer
PHASE2Recruiting
12 participants
Started: Oct 23, 2024 · Completed: Oct 23, 2026
1 condition1 sponsor1 location
NCT06520020
Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study
NARecruiting
30 participants
Started: Oct 23, 2024 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT06754150
Shoulder Innovations Clinical Data Registry
N/ARecruiting
2,500 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2039
1 condition1 sponsor4 locations
NCT06631053
FIT Exercise in 30d of ULLS-induced Muscle Disuse
NARecruiting
16 participants
Started: Oct 23, 2024 · Completed: Sep 1, 2025
2 conditions3 sponsors1 location
NCT07155954
Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes
N/ARecruiting
779 participants
Started: Oct 23, 2024 · Completed: Oct 22, 2027
4 conditions1 sponsor1 location
NCT06615401
Understanding Perceived Access and Receipt of Gender-affirming Treatments Among Transgender Veterans
N/ARecruiting
700 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06617013
GERD in Children With Cystic Fibrosis
NARecruiting
20 participants
Started: Oct 23, 2024 · Completed: Apr 30, 2025
2 conditions2 sponsors1 location
NCT06723912
Implementation of a Health Action Process Approach-Based Program for People on Hemodialysis Treatment
NARecruiting
64 participants
Started: Oct 23, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06546696
The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings
NARecruiting
750 participants
Started: Oct 23, 2024 · Completed: Dec 1, 2028
1 condition1 sponsor1 location
NCT06010719
Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute Malnutrition
PHASE4Recruiting
3,000 participants
Started: Oct 23, 2024 · Completed: Dec 29, 2028
2 conditions3 sponsors1 location
NCT06337318
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
PHASE3Recruiting
600 participants
Started: Oct 23, 2024 · Completed: Mar 31, 2032
2 conditions1 sponsor229 locations
NCT06781944
OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)
PHASE3Recruiting
144 participants
Started: Oct 23, 2024 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT06625151
Perfectionism and Daily Coping and Emotion Regulation Processes: A Trial of Two Explanatory Feedback Interventions
NARecruiting
200 participants
Started: Oct 23, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06902194
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
N/ARecruiting
250 participants
Started: Oct 23, 2024 · Completed: Nov 30, 2025
2 conditions2 sponsors2 locations
NCT04706026
A Pilot Study of Local Anesthesia for Inguinal Hernia Surgery in Older Adults
NARecruiting
80 participants
Started: Oct 23, 2024 · Completed: Mar 1, 2027
2 conditions4 sponsors3 locations
NCT06766058
Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.
NARecruiting
300 participants
Started: Oct 22, 2024 · Completed: Oct 1, 2026
1 condition1 sponsor1 location
NCT06130956
The Effect of a 2-week Preoperative Vegan Diet Versus Omnivorous Diet on the Protein Turnover in the Osteoarthritic Knee
NARecruiting
40 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2026
2 conditions3 sponsors2 locations
NCT06614829
Patient Reported Experiences and Outcomes Associated with Standard C-Section Wound Closure Versus STRATAFIX/DERMABOND PRINEO Wound Closure (CS-PREO)
NARecruiting
68 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06640114
Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis
NARecruiting
40 participants
Started: Oct 22, 2024 · Completed: Feb 27, 2026
1 condition1 sponsor1 location
NCT06583083
Sintilimab With P-GEMOX Versus the P-GEMOX in the Teatment of Advanced-stage Extranodal Natural Killer/T Cell Lymphoma
PHASE2Recruiting
84 participants
Started: Oct 22, 2024 · Completed: Aug 28, 2026
1 condition1 sponsor1 location
NCT06014879
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
NARecruiting
250 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06615739
Comprehensive SRS Regenerex Tissue Attachment
N/ARecruiting
103 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06681012
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NARecruiting
330 participants
Started: Oct 22, 2024 · Completed: Nov 30, 2025
2 conditions1 sponsor8 locations
NCT06569537
Comparison of Compounded Topical Anesthetics
PHASE4Recruiting
60 participants
Started: Oct 22, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06465498
Investigating ACute HeArt FailuRe Decongestion Guided by Lung UltraSonography
NARecruiting
222 participants
Started: Oct 22, 2024 · Completed: Aug 30, 2026
1 condition2 sponsors4 locations
NCT06218030
Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study
PHASE4Recruiting
10 participants
Started: Oct 22, 2024 · Completed: May 1, 2026
1 condition1 sponsor1 location
NCT06444854
Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study
NARecruiting
130 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06643312
TPAD for Recovery of Standing After Severe SCI
NARecruiting
50 participants
Started: Oct 22, 2024 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT06719414
Application of Amide Proton Transfer-weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
N/ARecruiting
320 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2028
1 condition2 sponsors2 locations
NCT06716853
A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients Suffering from Metastatic Renal Cell Carcinoma
PHASE1/PHASE2Recruiting
12 participants
Started: Oct 22, 2024 · Completed: Sep 30, 2026
1 condition4 sponsors1 location
NCT06650228
Cardiovascular Disease Risk Factors and Healthy Lifestyle Behaviours in Patients with Ankylosing Spondylitis
N/ARecruiting
42 participants
Started: Oct 22, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06803589
Growth Hormone for the Treatment of Gastroparesis
EARLY_PHASE1Recruiting
10 participants
Started: Oct 22, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT06683651
A Study in Chinese Patients With Acquired Blepharoptosis
PHASE3Recruiting
180 participants
Started: Oct 22, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor21 locations
NCT06631521
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
PHASE1Recruiting
30 participants
Started: Oct 22, 2024 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location